Headache and Migraine
MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Published in Pharma Law Weekly, September 22nd, 2009
MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) announced that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX™ orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society. Data from this Phase 3 trial show the potential of LEVADEX to be effective in treating acute migraine as well as a broad spectrum of migraine, including migraine subpopulations that are often resistant to current therapies such as triptans, migraine with moderate and severe pain, migraine with nausea and vomiting and migraine with and without aura.
"A majority of patients are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-09-22)
More Articles from Pharma Law Weekly
- AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago - AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' to Cong. Hare - Aetna
Aetna and the Aetna Foundation Sponsor Health Affairs Issue Offering Solutions to Address Rising Health Care Costs - Aging
Research on aging published by L.H. Plawecki et al - American Medical Association
AMA Reaction to President Obama's Address on Health-System Reform - American Medical Informatics Association
David Blumenthal and Aneesh Chopra Give Keynote Addresses at AMIA's Conference on Anticipating and Addressing Unintended Consequences of HIT and Policy - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
